Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0HOJ market cap is 5.02B. The company's latest EPS is USD -8.3399 and P/E is -11.35.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.51M | 793.74M | 180.08M | 204.04M | 249.38M |
| Operating Income | -361.33M | 308.71M | -641.98M | -537.52M | -486.28M |
| Net Income | -347.69M | 313.88M | -644.09M | -557.52M | -506.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 707.69M | 1.72B | 1.25B | 1.35B | 1.05B |
| Total Liabilities | 243.34M | 248.31M | 281.49M | 835.23M | 918.64M |
| Total Equity | 464.36M | 1.47B | 970.74M | 514.68M | 130.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -278.02M | 387.04M | -298.65M | -502.28M | -436.85M |
| Investing | -16.47M | -434.25M | -225.86M | -149.54M | 274.04M |
| Financing | 340.64M | 617.76M | 50.72M | 561.81M | 119.23M |
| Market Cap | 5.02B |
| Price to Earnings Ratio | -11.35 |
| Price to Sales Ratio | 23.08 |
| Price to Cash Ratio | 80.74 |
| Price to Book Ratio | 44.07 |
| Dividend Yield | - |
| Shares Outstanding | 60.79M |
| Average Volume (1 week) | 1.23k |
| Average Volume (1 Month) | 713 |
| 52 Week Change | 0.00% |
| 52 Week High | 82.54 |
| 52 Week Low | 82.54 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Blueprint Medicines Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.blueprintmedicines.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
